Compare
Innospec Inc. vs Ingevity Corp vs Balchem Corp vs Solstice Advanced Materials Inc.
| Latest fiscal year | Innospec Inc. IOSP | Ingevity Corp NGVT | Balchem Corp BCPC | Solstice Advanced Materials Inc. SOLS |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $1.78B | $1.17B | $1.04B | $3.89B |
| Revenue growth (YoY) | -3.7% | -2.7% | +8.8% | +3.1% |
| Gross margin | 27.7% | 39.5% | 35.7% | 32.2% (computed) |
| Operating margin | 7.3% | 35.9% | 20.2% | n/a |
| Net margin | 6.6% | -14.3% | 14.9% | 6.1% |
| Net income | $116.60M | -$167.10M | $154.84M | $237.00M |
| EPS (Diluted) | $4.67 | -$4.61 | $4.75 | $1.49 |
| Operating cash flow | $138.30M | $331.20M | $216.56M | $455.00M |
| Free cash flow | n/a | $273.50M | n/a | $119.00M |
| Cash & equivalents | $292.50M | $78.10M | $74.57M | $534.00M |
| Total assets | $1.83B | $1.65B | $1.69B | $5.67B |
| Total liabilities | $499.50M | $1.62B | $428.84M | $4.30B |
| Shareholders' equity | $1.33B | $29.70M | $1.26B | $1.38B |
| Return on year-end equity | 8.8% | -562.6% | 12.3% | 17.2% |
| Shares outstanding | n/a | 35.49M | 32.06M | 158.75M |
Revenue, most recent five fiscal years
| Fiscal year | Innospec Inc. | Ingevity Corp | Balchem Corp | Solstice Advanced Materials Inc. |
|---|---|---|---|---|
| Latest | $1.78B Ended 2025-12-31 | $1.17B Ended 2025-12-31 | $1.04B Ended 2025-12-31 | $3.89B Ended 2025-12-31 |
| 1 year earlier | $1.85B Ended 2024-12-31 | $1.20B Ended 2024-12-31 | $953.68M Ended 2024-12-31 | $3.77B Ended 2024-12-31 |
| 2 years earlier | $1.95B Ended 2023-12-31 | $1.22B Ended 2023-12-31 | $922.44M Ended 2023-12-31 | $3.65B Ended 2023-12-31 |
| 3 years earlier | $1.96B Ended 2022-12-31 | $1.67B Ended 2022-12-31 | $942.36M Ended 2022-12-31 | n/a |
| 4 years earlier | $1.48B Ended 2021-12-31 | $1.39B Ended 2021-12-31 | $799.02M Ended 2021-12-31 | n/a |